Bio-Rad Laboratories Profit Margin 2006-2019 | BIO
Current and historical gross margin, operating margin and net profit margin for Bio-Rad Laboratories (BIO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bio-Rad Laboratories net profit margin as of June 30, 2019 is 39.32%.
|Bio-Rad Laboratories Annual Profit Margins
|Bio-Rad Laboratories Quarterly Profit Margins
||Medical Products Manufacturing
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.